Free Trial

Exponent, Inc. $EXPO Shares Acquired by Vestmark Advisory Solutions Inc.

Exponent logo with Business Services background

Key Points

  • Vestmark Advisory Solutions Inc. increased its holdings in Exponent, Inc. (NASDAQ: EXPO) by 125.6% during the first quarter, acquiring an additional 37,975 shares to own a total of 68,198 shares, valued at $5.5 million.
  • Exponent reported $0.52 EPS for the latest quarter, exceeding consensus estimates of $0.48, along with a year-over-year revenue growth of 7.3% to $132.87 million.
  • The company announced a quarterly dividend of $0.30 per share, set to be paid on September 19, with an annualized dividend yield of 1.7%.
  • Looking to export and analyze Exponent data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Vestmark Advisory Solutions Inc. raised its holdings in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 125.6% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 68,198 shares of the business services provider's stock after acquiring an additional 37,975 shares during the quarter. Vestmark Advisory Solutions Inc. owned approximately 0.13% of Exponent worth $5,528,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in EXPO. Franklin Resources Inc. increased its position in shares of Exponent by 5.4% during the fourth quarter. Franklin Resources Inc. now owns 3,710 shares of the business services provider's stock worth $331,000 after acquiring an additional 189 shares in the last quarter. Bank of Montreal Can grew its stake in shares of Exponent by 1.5% in the 4th quarter. Bank of Montreal Can now owns 8,747 shares of the business services provider's stock worth $779,000 after buying an additional 131 shares during the last quarter. Barclays PLC raised its position in shares of Exponent by 88.5% in the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock worth $16,209,000 after purchasing an additional 85,395 shares during the last quarter. First Trust Advisors LP lifted its position in Exponent by 74.1% in the 4th quarter. First Trust Advisors LP now owns 52,439 shares of the business services provider's stock valued at $4,672,000 after acquiring an additional 22,323 shares in the last quarter. Finally, MetLife Investment Management LLC lifted its stake in Exponent by 8.3% during the 4th quarter. MetLife Investment Management LLC now owns 58,331 shares of the business services provider's stock valued at $5,197,000 after acquiring an additional 4,461 shares during the period. 92.37% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Exponent

In other Exponent news, CEO Catherine Corrigan sold 4,896 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $71.09, for a total transaction of $348,056.64. Following the transaction, the chief executive officer directly owned 81,342 shares in the company, valued at $5,782,602.78. This represents a 5.68% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Joseph Rakow sold 1,573 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The disclosure for this sale can be found here. Insiders sold a total of 10,064 shares of company stock worth $735,621 over the last quarter. 1.60% of the stock is owned by corporate insiders.

Exponent Trading Up 0.6%

EXPO stock traded up $0.3880 during trading on Tuesday, reaching $69.5080. The stock had a trading volume of 508,682 shares, compared to its average volume of 314,937. Exponent, Inc. has a 52 week low of $63.81 and a 52 week high of $115.75. The stock's 50 day moving average is $73.29 and its two-hundred day moving average is $78.48. The firm has a market cap of $3.51 billion, a PE ratio of 34.72 and a beta of 0.89.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.04. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The company had revenue of $132.87 million for the quarter, compared to the consensus estimate of $130.82 million. During the same quarter last year, the company earned $0.57 EPS. The firm's quarterly revenue was up 7.3% on a year-over-year basis. On average, research analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 19th. Stockholders of record on Friday, September 5th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, September 5th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.7%. Exponent's dividend payout ratio is presently 60.00%.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines